Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1995 Mar;146(3):635–642.

Up-regulation of T helper 2 and down-regulation of T helper 1 cytokines during murine retrovirus-induced immunodeficiency syndrome enhances susceptibility of a resistant mouse strain to Leishmania amazonensis.

M Barral-Netto 1, J S da Silva 1, A Barral 1, S Reed 1
PMCID: PMC1869162  PMID: 7887446

Abstract

Resistance to and recovery from leishmania infection is dependent on cell-mediated immunity. C57BL/6 mice are resistant to Leishmania amazonensis (La) infection but susceptible to LP-BM5 murine leukemia virus (MuLV) infection. MuLV infection leads to a state of immunodeficiency characterized by severe compromise of cell-mediated immunity. When infected with La alone, C57BL/6 mice developed a small transient lesion that evolved to spontaneous healing or a lesion with extremely slow growth. Lesions were predominantly comprised of a lympho-macrophagic infiltrate with few parasitized macrophages. When infected with La and, 4 weeks later, with MuLV (La-MuLV), the mice developed a large uncontrolled nonhealing lesion containing vacuolated and heavily parasitized macrophages. In contrast, mice infected with MuLV first and La 4 weeks later (MuLV-La) developed a small but persistent lesion, characterized histologically by a small number of heavily parasitized macrophages and few lymphocytes. Eight weeks after MuLV infection, both had similar immunological profiles with decreased lymphocyte proliferation, diminished production of interferon-gamma, and high production of interleukins 4 and 10. At the time of L. amazonensis infection, La-MuLV animals have a normal T cell function whereas in MuLV-La mice this function is already impaired; this may influence the recruitment of macrophages to the site of leishmania injection.

Full text

PDF
635

Images in this article

640Figure 5
on p.640

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altés J., Salas A., Riera M., Udina M., Galmés A., Balanzat J., Ballesteros A., Buades J., Salvá F., Villalonga C. Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literature. AIDS. 1991 Feb;5(2):201–207. [PubMed] [Google Scholar]
  2. Aziz D. C., Hanna Z., Jolicoeur P. Severe immunodeficiency disease induced by a defective murine leukaemia virus. Nature. 1989 Apr 6;338(6215):505–508. doi: 10.1038/338505a0. [DOI] [PubMed] [Google Scholar]
  3. Barral-Netto M., Reed S. G., Sadigursky M., Sonnenfeld G. Specific immunization of mice against Leishmania mexicana amazonensis using solubilized promastigotes. Clin Exp Immunol. 1987 Jan;67(1):11–19. [PMC free article] [PubMed] [Google Scholar]
  4. Barral A., Almeida R. P., de Jesus A. R., Medeiros Neto E., Santos I. A., Johnson W., Jr The relevance of characterizing Leishmania from cutaneous lesions. A simple approach for isolation. Mem Inst Oswaldo Cruz. 1987 Oct-Dec;82(4):579–579. doi: 10.1590/s0074-02761987000400018. [DOI] [PubMed] [Google Scholar]
  5. Buller R. M., Yetter R. A., Fredrickson T. N., Morse H. C., 3rd Abrogation of resistance to severe mousepox in C57BL/6 mice infected with LP-BM5 murine leukemia viruses. J Virol. 1987 Feb;61(2):383–387. doi: 10.1128/jvi.61.2.383-387.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chattopadhyay S. K., Morse H. C., 3rd, Makino M., Ruscetti S. K., Hartley J. W. Defective virus is associated with induction of murine retrovirus-induced immunodeficiency syndrome. Proc Natl Acad Sci U S A. 1989 May;86(10):3862–3866. doi: 10.1073/pnas.86.10.3862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cheung S. C., Chattopadhyay S. K., Hartley J. W., Morse H. C., 3rd, Pitha P. M. Aberrant expression of cytokine genes in peritoneal macrophages from mice infected with LP-BM5 MuLV, a murine model of AIDS. J Immunol. 1991 Jan 1;146(1):121–127. [PubMed] [Google Scholar]
  8. Coppola F., Recchia S., Ferrari A., Del Sedime L. Visceral leishmaniasis in AIDS with gastric involvement. Gastrointest Endosc. 1992 Jan-Feb;38(1):76–78. doi: 10.1016/s0016-5107(92)70340-x. [DOI] [PubMed] [Google Scholar]
  9. Da-Cruz A. M., Machado E. S., Menezes J. A., Rutowitsch M. S., Coutinho S. G. Cellular and humoral immune responses of a patient with American cutaneous leishmaniasis and AIDS. Trans R Soc Trop Med Hyg. 1992 Sep-Oct;86(5):511–512. doi: 10.1016/0035-9203(92)90089-u. [DOI] [PubMed] [Google Scholar]
  10. Delsedime L., Coppola F., Mazzucco G. Gastric localization of systemic leishmaniasis in a patient with AIDS. Histopathology. 1991 Jul;19(1):93–95. doi: 10.1111/j.1365-2559.1991.tb00901.x. [DOI] [PubMed] [Google Scholar]
  11. Eckwalanga M., Marussig M., Tavares M. D., Bouanga J. C., Hulier E., Pavlovitch J. H., Minoprio P., Portnoï D., Rénia L., Mazier D. Murine AIDS protects mice against experimental cerebral malaria: down-regulation by interleukin 10 of a T-helper type 1 CD4+ cell-mediated pathology. Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):8097–8101. doi: 10.1073/pnas.91.17.8097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fenske S., Stellbrink H. J., Albrecht H., Greten H. Visceral leishmaniasis in an HIV-infected patient: clinical features and response to treatment. Klin Wochenschr. 1991 Oct 31;69(17):793–796. doi: 10.1007/BF01744270. [DOI] [PubMed] [Google Scholar]
  13. Fillola G., Corberand J. X., Laharrague P. F., Levenes H., Massip P., Recco P. Peripheral intramonocytic leishmanias in an AIDS patient. J Clin Microbiol. 1992 Dec;30(12):3284–3285. doi: 10.1128/jcm.30.12.3284-3285.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gazzinelli R. T., Hartley J. W., Fredrickson T. N., Chattopadhyay S. K., Sher A., Morse H. C., 3rd Opportunistic infections and retrovirus-induced immunodeficiency: studies of acute and chronic infections with Toxoplasma gondii in mice infected with LP-BM5 murine leukemia viruses. Infect Immun. 1992 Oct;60(10):4394–4401. doi: 10.1128/iai.60.10.4394-4401.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gazzinelli R. T., Makino M., Chattopadhyay S. K., Snapper C. M., Sher A., Hügin A. W., Morse H. C., 3rd CD4+ subset regulation in viral infection. Preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice. J Immunol. 1992 Jan 1;148(1):182–188. [PubMed] [Google Scholar]
  16. Gillis S., Smith K. A. Long term culture of tumour-specific cytotoxic T cells. Nature. 1977 Jul 14;268(5616):154–156. doi: 10.1038/268154a0. [DOI] [PubMed] [Google Scholar]
  17. Hartley J. W., Fredrickson T. N., Yetter R. A., Makino M., Morse H. C., 3rd Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains. J Virol. 1989 Mar;63(3):1223–1231. doi: 10.1128/jvi.63.3.1223-1231.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jolicoeur P. Murine acquired immunodeficiency syndrome (MAIDS): an animal model to study the AIDS pathogenesis. FASEB J. 1991 Jul;5(10):2398–2405. doi: 10.1096/fasebj.5.10.2065888. [DOI] [PubMed] [Google Scholar]
  19. Kiderlen A. F., Kaufmann S. H., Lohmann-Matthes M. L. Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon. Eur J Immunol. 1984 Oct;14(10):964–967. doi: 10.1002/eji.1830141019. [DOI] [PubMed] [Google Scholar]
  20. Klinken S. P., Fredrickson T. N., Hartley J. W., Yetter R. A., Morse H. C., 3rd Evolution of B cell lineage lymphomas in mice with a retrovirus-induced immunodeficiency syndrome, MAIDS. J Immunol. 1988 Feb 15;140(4):1123–1131. [PubMed] [Google Scholar]
  21. Klinman D. M., Morse H. C., 3rd Characteristics of B cell proliferation and activation in murine AIDS. J Immunol. 1989 Feb 15;142(4):1144–1149. [PubMed] [Google Scholar]
  22. Makino M., Morse H. C., 3rd, Fredrickson T. N., Hartley J. W. H-2-associated and background genes influence the development of a murine retrovirus-induced immunodeficiency syndrome. J Immunol. 1990 Jun 1;144(11):4347–4355. [PubMed] [Google Scholar]
  23. Molina R., López-Vélez R., Gutiérrez-Solar B., Jiménez I., Alvar J. Isolation of Leishmania infantum from the blood of a patient with AIDS using sandflies. Trans R Soc Trop Med Hyg. 1992 Sep-Oct;86(5):516–516. doi: 10.1016/0035-9203(92)90092-q. [DOI] [PubMed] [Google Scholar]
  24. Morse H. C., 3rd, Yetter R. A., Via C. S., Hardy R. R., Cerny A., Hayakawa K., Hugin A. W., Miller M. W., Holmes K. L., Shearer G. M. Functional and phenotypic alterations in T cell subsets during the course of MAIDS, a murine retrovirus-induced immunodeficiency syndrome. J Immunol. 1989 Aug 1;143(3):844–850. [PubMed] [Google Scholar]
  25. Mosier D. E., Yetter R. A., Morse H. C., 3rd Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice. J Exp Med. 1985 Apr 1;161(4):766–784. doi: 10.1084/jem.161.4.766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Mosmann T. R., Fong T. A. Specific assays for cytokine production by T cells. J Immunol Methods. 1989 Jan 17;116(2):151–158. doi: 10.1016/0022-1759(89)90198-1. [DOI] [PubMed] [Google Scholar]
  27. Pattengale P. K., Taylor C. R., Twomey P., Hill S., Jonasson J., Beardsley T., Haas M. Immunopathology of B-cell lymphomas induced in C57BL/6 mice by dualtropic murine leukemia virus (MuLV). Am J Pathol. 1982 Jun;107(3):362–377. [PMC free article] [PubMed] [Google Scholar]
  28. Scott P., Natovitz P., Coffman R. L., Pearce E., Sher A. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J Exp Med. 1988 Nov 1;168(5):1675–1684. doi: 10.1084/jem.168.5.1675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Silva J. S., Barral-Netto M., Reed S. G. Aggravation of both Trypanosoma cruzi and murine leukemia virus by concomitant infections. Am J Trop Med Hyg. 1993 Nov;49(5):589–597. doi: 10.4269/ajtmh.1993.49.589. [DOI] [PubMed] [Google Scholar]
  30. Yetter R. A., Buller R. M., Lee J. S., Elkins K. L., Mosier D. E., Fredrickson T. N., Morse H. C., 3rd CD4+ T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS). J Exp Med. 1988 Aug 1;168(2):623–635. doi: 10.1084/jem.168.2.623. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES